DR. HALLAND
LIVE

Serial Number

86609067

Owner

5H MEDIA, INC.

Attorney

John Cyril Malloy, III

First Use Date

Oct 31, 2013

Filing Date

Apr 24, 2015

Add to watchlist:

No watchlists yet
View on USPTO

DR. HALLAND Trademark

Serial Number: 86609067 • Registration: 4986488

DR. HALLAND is a trademark filed by 5H MEDIA, INC. on April 24, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

5H MEDIA, INC. (7 trademarks)

1317 EDGEWATER DR., SUITE 800
ORLANDO, FL 32804

Entity Type: 03

H. CHEN, MD, INC. (7 trademarks)

41 PARK AVENUE
NEW YORK, NY 10016

Entity Type: 03

Dr. Halland Medical, PLLC

41 Park Avenue, Suite 1C
New York, NY 10016

Entity Type: 99

Trademark Details

Filing Date

April 24, 2015

Registration Date

June 28, 2016

First Use Anywhere

October 31, 2013

First Use in Commerce

May 1, 2014

Published for Opposition

April 12, 2016

Goods & Services

Medical services, namely, non-invasive medical procedures for the treatment of knee and spine conditions, muscle and joint conditions, and sports related injuries; Medical services, namely, administering regenerative medicine therapies for healing the body; [ medical products for joint pain and back pain relief, namely, supplements, topical solutions, and injections; ] Medical services, namely, non-invasive cosmetic medical procedures for treatment of the skin, scalp, and hair loss conditions and cosmetic skin care services, namely, anti-aging treatments in the nature of topical application of vitamins, stem cells, chemical peels, cytokines, growth factors and injectable and intravenous delivery of vitamins, stem cells, chemical peels, cytokines, growth factors, facial injections [, and non-surgical facelift, namely, facial injections and neck injections with stem cells, cytokines, and growth factor preparations ]

[ Pharmaceuticals for the treatment of hair loss, joint pain, back pain in the form of injections, topical solutions, and pill supplements; ] pharmaceuticals for the treatment of aging in the nature of topical solutions and injections

Filing History

TEAS SECTION 8 & 9 RECEIVED
Jun 25, 2026 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jun 28, 2025 REM2
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Aug 9, 2023 ASCK
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jan 13, 2023 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jan 13, 2023 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 13, 2023 APRE
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 27, 2022 ASGN
TEAS SECTION 8 & 15 RECEIVED
Jun 28, 2022 E815
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 20, 2017 ASGN
REGISTERED-PRINCIPAL REGISTER
Jun 28, 2016 R.PR
PUBLISHED FOR OPPOSITION
Apr 12, 2016 PUBO
NOTICE OF PUBLICATION
Mar 23, 2016 NPUB
EXAMINERS AMENDMENT MAILED
Mar 9, 2016 CNEA
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 9, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 9, 2016 XAEC
EXAMINERS AMENDMENT -WRITTEN
Mar 9, 2016 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Mar 4, 2016 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Mar 1, 2016 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 8, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 6, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 5, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 5, 2016 TROA
NON-FINAL ACTION MAILED
Aug 5, 2015 CNRT
NON-FINAL ACTION WRITTEN
Aug 4, 2015 CNRT
ASSIGNED TO EXAMINER
Aug 4, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 5, 2015 NWOS